Entropy Technologies’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
Entropy Technologies's LKFT Position: Q3 2026 in Review
Entropy Technologies opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 29,912 shares worth $887K. The stake represents 0.03% of the portfolio and ranks #644 among its holdings.
95 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- Entropy Technologies held 29,912 shares of Lakefront Biotherapeutics American Depositary Shares worth $887K as of Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares was a new Entropy Technologies position in Q3 2026.
- Lakefront Biotherapeutics American Depositary Shares made up 0.03% of Entropy Technologies's portfolio in Q3 2026, its #644 holding.
- 95 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on Entropy Technologies's 13F filing for Q3 2026, filed 13 Nov 2026.